Patient No. | Response to the initial increased dose bortezomib therapy | Successive treatments after the initial increased bortezomib treatment | Treatment duration of the second increased dose bortezomib treatment (months) |
1 | PD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 4 |
2 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 8## |
3 | SD | - | * |
4 | SD | # | * |
5 | SD | # | * |
6 | SD | - | * |
7 | SD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 2## |
8 | SD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 9## |
9 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 7## |
10 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 6 |
11 | PD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 9## |
12 | PD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 13## |
13 | * | - | * |
14 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 3 |
15 | PD | BDL15 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/m2 on Days 1-2, and Len 15 mg/body on Days 1-28 | 3 |
16 | SD | - | * |
17 | PD | - | * |
18 | * | BD Bor 1.6 mg/m2 on Day 1 and Dex 20 mg/body on Days 1-2 | 1 |
19 | SD | # | * |
20 | PD | # | * |
21 | * | # | * |
22 | PD | - | * |